Insider Transactions in Q4 2021 at Prometheus Biosciences, Inc. (RXDX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,400
+50.0%
|
$30,800
$2.9 P/Share
|